EW
Edwards Lifesciences Corp
NYSE: EW · HEALTHCARE · MEDICAL DEVICES
$81.22
-1.29% today
Updated 2026-04-29
Market cap
$46.83B
P/E ratio
43.90
P/S ratio
7.43x
EPS (TTM)
$1.85
Dividend yield
—
52W range
$72 – $88
Volume
5.0M
WallStSmart proprietary scores
61
out of 100
Grade: C+
Hold
Investment rating
6.0
Growth
B4.8
Quality
C7.5
Profitability
B+6.0
Valuation
B2/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$97.15
+19.61%
12-Month target
$53.88
-33.66%
Intrinsic (DCF)
$264.83
Margin of safety
+70.04%
5 Strong Buy16 Buy10 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $353.50M — positive
+ Revenue growth 16.70% QoQ
+ 70.04% below intrinsic value
Risks
- Piotroski 2/9 — weak financial health
- P/E 43.90x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $5.38B | $6.00B | $5.44B | $6.07B | $6.30B | $6.9B |
| Net income | $1.52B | $1.40B | $4.17B | $1.07B | $380.70M | — |
| EPS | — | — | — | — | $1.85 | $3.01 |
| Free cash flow | $953.40M | $629.50M | $289.90M | $1.33B | $353.50M | — |
| Profit margin | 28.28% | 23.35% | 76.75% | 17.69% | 17.40% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-09 | ULLEM, SCOTT B. | Sale | 13,000 | — |
| 2026-04-09 | ULLEM, SCOTT B. | Buy | 13,000 | $59.26 |
| 2026-04-09 | ULLEM, SCOTT B. | Sale | 8,324 | $79.79 |
Peer comparison
Smart narrative
Edwards Lifesciences Corp trades at $81.22. representing a P/E of 43.90x trailing earnings. Our Smart Value Score of 61/100 indicates the stock is good. The company scores 2/9 on the Piotroski F-Score. TTM revenue stands at $6.30B. with profit margins at 17.40%. Our DCF model estimates intrinsic value at $264.83.
Frequently asked questions
What is Edwards Lifesciences Corp's stock price?
Edwards Lifesciences Corp (EW) trades at $81.22.
Is Edwards Lifesciences Corp overvalued?
Smart Value Score 61/100 (Grade C+, Hold). DCF value $264.83.
What is the price target of Edwards Lifesciences Corp (EW)?
The analyst target price is $97.15, representing +19.6% upside from the current price of $81.22.
What is the intrinsic value of Edwards Lifesciences Corp (EW)?
Based on our DCF model, intrinsic value is $264.83, a +70.0% margin of safety versus $81.22.
What is the future stock price of EW by 2030?
Our research-backed model estimates Edwards Lifesciences Corp could reach $202.63 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Edwards Lifesciences Corp's revenue?
TTM revenue is $6.30B.
Piotroski F-Score?
2/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio7.43x
ROE10.30%
Beta0.95
50D MA$81.88
200D MA$80.97
Shares out0.58B
Float0.58B
Short ratio—
Avg volume5.0M
Performance
1 week+1.88%
1 month+1.42%
3 months-0.33%
YTD-4.73%
1 year—
3 years—
5 years—